These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 21375477)

  • 1. The psychoactive effects of antidepressants and their association with suicidality.
    Goldsmith L; Moncrieff J
    Curr Drug Saf; 2011 Apr; 6(2):115-21. PubMed ID: 21375477
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Severe anticholinergic side effects with venlafaxine-fluoxetine combination.
    Benazzi F
    Can J Psychiatry; 1997 Nov; 42(9):980-1. PubMed ID: 9429070
    [No Abstract]   [Full Text] [Related]  

  • 3. Prevalence of risk factors for suicide in patients prescribed venlafaxine, fluoxetine, and citalopram.
    Mines D; Hill D; Yu H; Novelli L
    Pharmacoepidemiol Drug Saf; 2005 Jun; 14(6):367-72. PubMed ID: 15883980
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adverse Effects of Antidepressants Reported by a Large International Cohort: Emotional Blunting, Suicidality, and Withdrawal Effects.
    Read J; Williams J
    Curr Drug Saf; 2018; 13(3):176-186. PubMed ID: 29866014
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Agitated "unipolar" depression re-conceptualized as a depressive mixed state: implications for the antidepressant-suicide controversy.
    Akiskal HS; Benazzi F; Perugi G; Rihmer Z
    J Affect Disord; 2005 Apr; 85(3):245-58. PubMed ID: 15780694
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Venlafaxine compared with fluoxetine in outpatients with depression and concomitant anxiety.
    De Nayer A; Geerts S; Ruelens L; Schittecatte M; De Bleeker E; Van Eeckhoutte I; Evrard JL; Linkowski P; Fossion P; Leyman S; Mignon A
    Int J Neuropsychopharmacol; 2002 Jun; 5(2):115-20. PubMed ID: 12135535
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fluoxetine and concomitant centrally acting medication use during clinical trials of depression: the absence of an effect related to agitation and suicidal behavior.
    Wernicke JF; Sayler ME; Koke SC; Pearson DK; Tollefson GD
    Depress Anxiety; 1997; 6(1):31-9. PubMed ID: 9394873
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fluoxetine and suicide: a meta-analysis of controlled trials of treatment for depression.
    Beasley CM; Dornseif BE; Bosomworth JC; Sayler ME; Rampey AH; Heiligenstein JH; Thompson VL; Murphy DJ; Masica DN
    BMJ; 1991 Sep; 303(6804):685-92. PubMed ID: 1833012
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Venlafaxine-fluoxetine interaction.
    Benazzi F
    J Clin Psychopharmacol; 1999 Feb; 19(1):96-8. PubMed ID: 9934950
    [No Abstract]   [Full Text] [Related]  

  • 10. Venlafaxine versus fluoxetine in the treatment of atypical anorectic outpatients: a preliminary study.
    Ricca V; Mannucci E; Paionni A; Di Bernardo M; Cellini M; Cabras PL; Rotella CM
    Eat Weight Disord; 1999 Mar; 4(1):10-4. PubMed ID: 10728173
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A double-blind comparison of venlafaxine and fluoxetine in patients hospitalized for major depression and melancholia. The Venlafaxine French Inpatient Study Group.
    Clerc GE; Ruimy P; Verdeau-Pallès J
    Int Clin Psychopharmacol; 1994 Sep; 9(3):139-43. PubMed ID: 7814822
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A randomized, open-label comparison of venlafaxine and fluoxetine in depressed outpatients.
    Diaz-Martinez A; Benassinni O; Ontiveros A; Gonzalez S; Salin R; Basquedano G; Martinez RA
    Clin Ther; 1998; 20(3):467-76. PubMed ID: 9663362
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fluoxetine and suicidal ideation in minor depression.
    Stone MB; Hammad TA
    J Psychiatr Res; 2014 Jan; 48(1):131-2. PubMed ID: 24099987
    [No Abstract]   [Full Text] [Related]  

  • 14. Global benefit-risk assessment of antidepressants: venlafaxine XR and fluoxetine.
    Entsuah R; Gorman JM
    J Psychiatr Res; 2002; 36(3):111-8. PubMed ID: 11886688
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Venlafaxine-associated vaginal bleeding.
    Linnebur SA; Saseen JJ; Pace WD
    Pharmacotherapy; 2002 May; 22(5):652-5. PubMed ID: 12013367
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Erotomania induced by venlafaxine: a case study.
    Adamou M; Hale AS
    Acta Psychiatr Scand; 2003 Apr; 107(4):314-7. PubMed ID: 12662255
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment Emergent Suicidal Ideation in depressed older adults.
    Cristancho P; O'Connor B; Lenze EJ; Blumberger DM; Reynolds CF; Dixon D; Mulsant BH
    Int J Geriatr Psychiatry; 2017 Jun; 32(6):596-604. PubMed ID: 27162147
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased remission rates with venlafaxine compared with fluoxetine in hospitalized patients with major depression and melancholia.
    Tzanakaki M; Guazzelli M; Nimatoudis I; Zissis NP; Smeraldi E; Rizzo F
    Int Clin Psychopharmacol; 2000 Jan; 15(1):29-34. PubMed ID: 10836283
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical response and risk for reported suicidal ideation and suicide attempts in pediatric antidepressant treatment: a meta-analysis of randomized controlled trials.
    Bridge JA; Iyengar S; Salary CB; Barbe RP; Birmaher B; Pincus HA; Ren L; Brent DA
    JAMA; 2007 Apr; 297(15):1683-96. PubMed ID: 17440145
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel CYP2D6 and CYP2C19 variants identified in a patient with adverse reactions towards venlafaxine monotherapy and dual therapy with nortriptyline and fluoxetine.
    Chua EW; Foulds J; Miller AL; Kennedy MA
    Pharmacogenet Genomics; 2013 Sep; 23(9):494-7. PubMed ID: 23799451
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.